Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bone Neoplasms × dinutuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 3 Ganglioneuroblastoma 2 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Bone Neoplasms 1

Interventions

Ibandronic Acid 4 Zoledronic Acid 3 Tranexamic Acid 2 ridaforolimus 1 dinutuximab 1 Sodium Pertechnetate Tc 99m 1 Sodium Chloride 1 Neutrons 1 Fluoridation 1 Fibrin Tissue Adhesive 1 Diathermy 1 Denosumab 1 Cyproheptadine 1 Captopril 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06669013 2024-11-01

FollowTheDIN

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Recruiting

Bone Neoplasms, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡